Prudential Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $512K | Buy |
53,776
+40,986
| +320% | +$318K | ﹤0.01% | 1860 |
|
|
2025
Q4 | $99.8K | Sell |
12,790
-381,775
| -97% | -$2.76M | ﹤0.01% | 2120 |
|
|
2025
Q3 | $2.99M | Sell |
394,565
-34,770
| -8% | -$290K | ﹤0.01% | 1173 |
|
|
2025
Q2 | $3.85M | Sell |
429,335
-159,975
| -27% | -$1.49M | 0.01% | 1057 |
|
|
2025
Q1 | $4.42M | Sell |
589,310
-393,723
| -40% | -$3.18M | 0.01% | 891 |
|
|
2024
Q4 | $7.39M | Buy |
983,033
+90,603
| +10% | +$688K | 0.01% | 719 |
|
|
2024
Q3 | $6.78M | Buy |
892,430
+876,205
| +5,400% | +$6.66M | 0.01% | 847 |
|
|
2024
Q2 | $100K | Buy |
16,225
+1,760
| +12% | +$9.71K | ﹤0.01% | 2545 |
|
|
2024
Q1 | $73.5K | Hold |
14,465
| – | – | ﹤0.01% | 2556 |
|
|
2023
Q4 | $86.6K | Buy |
14,465
+460
| +3% | +$2.67K | ﹤0.01% | 2512 |
|
|
2023
Q3 | $99.2K | Hold |
14,005
| – | – | ﹤0.01% | 2447 |
|
|
2023
Q2 | $98.6K | Hold |
14,005
| – | – | ﹤0.01% | 2486 |
|
|
2023
Q1 | $152K | Sell |
14,005
-55
| -0.4% | -$529 | ﹤0.01% | 2427 |
|
|
2022
Q4 | $161K | Sell |
14,060
-225
| -2% | -$2.81K | ﹤0.01% | 2428 |
|
|
2022
Q3 | $155K | Buy |
14,285
+230
| +2% | +$2.96K | ﹤0.01% | 2483 |
|
|
2022
Q2 | $130K | Hold |
14,055
| – | – | ﹤0.01% | 2507 |
|
|
2022
Q1 | $228K | Buy |
14,055
+205
| +1% | +$3.29K | ﹤0.01% | 2481 |
|
|
2021
Q4 | $192K | Sell |
13,850
-1,250
| -8% | -$16.5K | ﹤0.01% | 2551 |
|
|
2021
Q3 | $217K | Buy |
15,100
+1,230
| +9% | +$19.4K | ﹤0.01% | 2450 |
|
|
2021
Q2 | $219K | Buy |
13,870
+240
| +2% | +$3.26K | ﹤0.01% | 2427 |
|
|
2021
Q1 | $139K | Sell |
13,630
-920
| -6% | -$9.49K | ﹤0.01% | 2428 |
|
|
2020
Q4 | $108K | Buy |
14,550
+1,870
| +15% | +$9.64K | ﹤0.01% | 2392 |
|
|
2020
Q3 | $43K | Buy |
12,680
+890
| +8% | +$3.81K | ﹤0.01% | 2392 |
|
|
2020
Q2 | $56K | Buy |
11,790
+590
| +5% | +$2.36K | ﹤0.01% | 2357 |
|
|
2020
Q1 | $22K | Buy |
11,200
+180
| +2% | +$496 | ﹤0.01% | 2322 |
|
|
2019
Q4 | $38K | Buy |
+11,020
| New | +$27.7K | ﹤0.01% | 2404 |
|
|
2019
Q3 | – | Sell |
-10,610
| Closed | -$40K | – | 2416 |
|
|
2019
Q2 | $40K | Buy |
10,610
+140
| +1% | +$842 | ﹤0.01% | 2432 |
|
|
2019
Q1 | $85K | Hold |
10,470
| – | – | ﹤0.01% | 2384 |
|
|
2018
Q4 | $84K | Sell |
10,470
-230
| -2% | -$1.79K | ﹤0.01% | 2314 |
|
|
2018
Q3 | $82K | Buy |
+10,700
| New | +$71.9K | ﹤0.01% | 2387 |
|
|
2014
Q3 | – | Sell |
-13,200
| Closed | -$168K | – | 2217 |
|
|
2014
Q2 | $168K | Buy |
+13,200
| New | +$128K | ﹤0.01% | 2303 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC